Results 81 to 90 of about 28,682 (177)

Diagnosis and typing of leukemia using a single peripheral blood cell through deep learning

Cancer Science, Volume 116, Issue 2, Page 533-543, February 2025.
This pioneering research investigates the manner in which cellular morphological responses are linked to the nature of genome information using deep learning. Abstract Leukemia is highly heterogeneous, meaning that different types of leukemia require different treatments and have different prognoses.
Geng Yan, Gao Mingyang, Shi Wei, Liang Hongping, Qin Liyuan, Liu Ailan, Kong Xiaomei, Zhao Huilan, Zhao Juanjuan, Qiang Yan   +9 more
wiley   +1 more source

[The mechanisms of taxodione-induced apoptosis in BCR-ABL-positive leukemia cells].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2019
Chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) are caused by a fusion protein, BCR-ABL, which induces cellular transformation by activating the signaling molecules, STAT5 and Akt. The specific BCR-ABL inhibitors including imatinib,
Yuki Uchihara, K. Tago, M. Funakoshi-Tago   +2 more
semanticscholar   +1 more source

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE

Zdravniški Vestnik, 2004
Background. Chronic myelogenous leukemia (CML) is a malignant clonal disorder of hematopoietic stem cell. In majority of patients we find reciprocal chromosomal translocation t (9.22) which result in fusion oncoprotein with tyrosine kinase activity.
Mateja Grat, Joško Vučkovič
doaj  

Adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a Brazilian hospital

Revista Brasileira de Hematologia e Hemoterapia, 2013
Objetive: The aim of this study was to identify the reasons for failure in adherence to imatinib mesylate treatment in chronic myeloid leukemia. Methods: A retrospective review was performed of
Samuel Roosevelt Campos dos Reis, Acy Telles de Souza Quixada, Sammara Tavares Nunes, Danielle Maria Camelo Cid, Jacqueline Holanda de Souza, Clara Maria Bastos Eloy da Costa, Carolina Bizelli Silveira, David Antonio Camelo Cid, Mariana Fatima Cabral de Oliveira   +8 more
doaj   +1 more source

Myeloid sarcoma: an uncommon presentation of myeloid neoplasms; a case series of 4 rare cases reported in a tertiary care institute

Autopsy and Case Reports, 2021
Myeloid sarcoma (MS) is a rare extramedullary neoplasm of myeloid cells, which can arise before, concurrently with, or following hematolymphoid malignancies.
Toyaja Jadhav, Puneet Baveja, Arijit Sen   +2 more
doaj  

Association of HLA antigens and BCR-ABL transcripts in leukemia patients with the Philadelphia chromosome

Revista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: This study aimed to verify the association between human leukocyte antigens and the bcr-abl fusion protein resulting from t(9;22)(q34;q11) in chronic leukemia myeloid and acute lymphoblastic leukemia patients.
Daiana Landenberger de Carvalho, Cristian Dias Barbosa, André Luiz de Carvalho, Sandra Trevisan Beck   +3 more
doaj   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Philadelphia Chromosome-negative, bcr/abl-positive Chronic Myelogenous Leukemia.

Journal of Nippon Medical School, 2001
K, Inokuchi, K, Dan
openaire   +3 more sources

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source